Constitutive_JJ
nuclear_JJ
NF-kappa_NN
B_NN
in_IN
cells_NNS
of_IN
the_DT
monocyte_NN
lineage_NN
._.

In_IN
monocytes_NNS
,_,
the_DT
nuclear_JJ
factor_NN
NF-kappa_NN
B_NN
has_VBZ
been_VBN
invoked_VBN
as_IN
an_DT
important_JJ
transcription_NN
factor_NN
in_IN
the_DT
expression_NN
of_IN
cytokine_NN
genes_NNS
,_,
of_IN
cell-surface_JJ
receptors_NNS
and_CC
in_IN
the_DT
expression_NN
of_IN
human_JJ
immunodeficiency_NN
virus_NN
._.

In_IN
such_JJ
cells_NNS
,_,
DNA_NN
binding_NN
activity_NN
of_IN
NF-kappa_NN
B_NN
can_MD
be_VB
detected_VBN
without_IN
intentional_JJ
stimulation_NN
._.

In_IN
our_PRP$
studies_NNS
,_,
cells_NNS
of_IN
the_DT
human_JJ
monocytic_JJ
line_NN
Mono_NN
Mac_NN
6_CD
,_,
cultured_VBN
in_IN
medium_NN
containing_VBG
fetal-calf_JJ
serum_NN
and_CC
low_JJ
levels_NNS
of_IN
lipopolysaccharide_NN
-LRB-_-LRB-
LPS_NN
-RRB-_-RRB-
,_,
also_RB
exhibit_VBP
such_JJ
'_''
constitutive_JJ
'_''
NF-kappa_NN
B_NN
,_,
as_IN
demonstrated_VBN
by_IN
mobility-shift_JJ
analysis_NN
of_IN
nuclear_JJ
extracts_NNS
._.

This_DT
nuclear_JJ
NF-kappa_NN
B_NN
was_VBD
still_RB
present_JJ
when_WRB
contaminant_JJ
LPS_NN
was_VBD
removed_VBN
by_IN
ultrafiltration_NN
and_CC
when_WRB
serum_NN
was_VBD
omitted_VBN
._.

Protein-DNA_JJ
complexes_NNS
of_IN
constitutive_JJ
NF-kappa_NN
B_NN
are_VBP
similar_JJ
in_IN
mobility_NN
to_TO
the_DT
LPS-induced_JJ
NF-kappa_NN
B_NN
and_CC
both_DT
are_VBP
recognized_VBN
by_IN
an_DT
antibody_NN
specific_JJ
to_TO
the_DT
p50_NN
subunit_NN
of_IN
NF-kappa_NN
B_NN
._.

By_IN
contrast_NN
,_,
treatment_NN
of_IN
cells_NNS
with_IN
pyrrolidine_NN
dithiocarbamate_NN
-LRB-_-LRB-
PDTC_NN
-RRB-_-RRB-
will_MD
only_RB
block_VB
LPS-induced_JJ
NF-kappa_NN
B_NN
,_,
but_CC
not_RB
the_DT
constitutive_JJ
binding_VBG
protein_NN
._.

Using_VBG
LPS-free_JJ
and_CC
serum-free_JJ
conditions_NNS
,_,
constitutive_JJ
NF-kappa_NN
B_NN
can_MD
be_VB
detected_VBN
in_IN
different_JJ
cell_NN
lines_NNS
of_IN
the_DT
monocytic_JJ
lineage_NN
-LRB-_-LRB-
HL60_NN
,_,
U937_NN
,_,
THP-1_NN
,_,
Mono_NN
Mac_NN
1_CD
and_CC
Mono_NN
Mac_NN
6_CD
-RRB-_-RRB-
,_,
but_CC
not_RB
in_IN
Molt_NN
4_CD
T_NN
cells_NNS
or_CC
K562_NN
stem_NN
cells_NNS
._.

When_WRB
ordered_VBN
according_VBG
to_TO
stage_NN
of_IN
maturation_NN
,_,
the_DT
amount_NN
of_IN
constitutive_JJ
NF-kappa_NN
B_NN
was_VBD
not_RB
increased_VBN
in_IN
more_RBR
mature_JJ
cell_NN
lines_NNS
._.

Furthermore_RB
,_,
when_WRB
inducing_VBG
differentiation_NN
in_IN
Mono_NN
Mac_NN
6_CD
cells_NNS
,_,
with_IN
vitamin_NN
D3_NN
,_,
no_DT
change_NN
in_IN
constitutive_JJ
or_CC
inducible_JJ
NF-kappa_NN
B_NN
can_MD
be_VB
detected_VBN
._.

Analysis_NN
of_IN
primary_JJ
cells_NNS
revealed_VBD
substantial_JJ
constitutive_JJ
NF-kappa_NN
B-binding_JJ
activity_NN
in_IN
blood_NN
monocytes_NNS
,_,
pleural_JJ
macrophages_NNS
and_CC
alveolar_JJ
macrophages_NNS
._.

The_DT
constitutive_JJ
NF-kappa_NN
B_NN
appears_VBZ
to_TO
be_VB
functionally_RB
active_JJ
,_,
since_IN
a_DT
low_JJ
level_NN
of_IN
tumor_NN
necrosis_NN
factor_NN
-LRB-_-LRB-
TNF_NN
-RRB-_-RRB-
transcript_NN
is_VBZ
detectable_JJ
in_IN
monocytes_NNS
,_,
and_CC
this_DT
level_NN
can_MD
be_VB
increased_VBN
by_IN
blocking_VBG
transcript_NN
degradation_NN
using_VBG
cycloheximide_NN
._.

The_DT
level_NN
of_IN
constitutive_JJ
NF-kappa_NN
B_NN
in_IN
these_DT
cells_NNS
is_VBZ
variable_JJ
and_CC
is_VBZ
frequently_RB
found_VBN
to_TO
be_VB
lower_JJR
in_IN
the_DT
more_RBR
mature_JJ
macrophages_NNS
._.

Constitutive_JJ
NF-kappa_NN
B_NN
was_VBD
not_RB
maintained_VBN
by_IN
autocrine_JJ
action_NN
of_IN
cytokines_NNS
TNF_NN
,_,
interleukin_NN
6_CD
,_,
interleukin_NN
10_CD
,_,
granulocyte-macrophage_JJ
colony-stimulating_JJ
factor_NN
or_CC
macrophage_NN
colony-stimulating_JJ
factor_NN
,_,
since_IN
neutralizing_VBG
antibodies_NNS
did_VBD
not_RB
reduce_VB
constitutive_JJ
DNA-binding_JJ
activity_NN
._.

Furthermore_RB
,_,
blockade_NN
of_IN
prostaglandin_NN
or_CC
leukotriene_NN
biosynthesis_NN
did_VBD
not_RB
affect_VB
constitutive_JJ
NF-kappa_NN
B_NN
._.

-LRB-_-LRB-
ABSTRACT_NN
TRUNCATED_VBN
AT_IN
400_CD
WORDS_NNS
-RRB-_-RRB-

